The Europe Antibody Drug Conjugates (ADC) market was valued at USD 2.90 Billion in 2024 and is expected to reach USD 9.73 Billion by 2032, growing at a CAGR of 16.3% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.